Caroline A Austin Selected Research

Caroline A Austin Research Topics

Disease

19	Neoplasms (Cancer) 03/2024 - 11/2005
12	Leukemia 01/2017 - 06/2004
3	Cardiotoxicity 01/2024 - 10/2019
3	Poisoning 10/2019 - 05/2002
3	Chromosome Breakage 01/2017 - 06/2012
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 06/2012
2	Neuroblastoma 10/2022 - 06/2002
2	Lung Neoplasms (Lung Cancer) 09/2013 - 01/2012
2	Hypersensitivity (Allergy) 08/2008 - 09/2004
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022
1	Decompression Sickness (Bends) 12/2012
1	Genomic Instability 03/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2008
1	Disease Progression 06/2008
1	Hematologic Neoplasms (Hematological Malignancy) 12/2007
1	Cardiac Arrhythmias (Arrythmia) 07/2006
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2005
1	Heart Diseases (Heart Disease) 11/2005
1	Ovarian Neoplasms (Ovarian Cancer) 07/2003

Drug/Important Bio-Agent (IBA)

13	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2002
12	PoisonsIBA 03/2024 - 06/2004
10	Etoposide (VP 16)FDA LinkGeneric 03/2024 - 09/2004
8	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2019 - 06/2004
7	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2023 - 09/2004
7	trioctyl phosphine oxide (TOPO)IBA 07/2011 - 05/2002
5	AnthracyclinesIBA 01/2024 - 05/2002
3	EnzymesIBA 01/2019 - 05/2002
3	DNA TopoisomerasesIBA 02/2010 - 01/2006
2	Peroxidase (Myeloperoxidase)IBA 03/2024 - 01/2017
2	DNA AdductsIBA 01/2022 - 03/2011
2	FlavonoidsIBA 02/2010 - 05/2007
2	DNA-Activated Protein KinaseIBA 06/2008 - 06/2004
2	Digitoxin FDA Link 07/2006 - 11/2005
2	SulfonamidesIBA 01/2006 - 09/2004
1	Topoisomerase II InhibitorsIBA 01/2024
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2024
1	XK 469 (XK469)IBA 01/2024
1	Adrenergic Agents (Adrenergic Drugs)IBA 10/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2022
1	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2021
1	IronIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019
1	vosaroxinIBA 01/2019
1	QuinolonesIBA 01/2019
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2019
1	Adenosine Triphosphatases (ATPase)IBA 01/2019
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2017
1	ChromatinIBA 02/2014
1	Proteins (Proteins, Gene)FDA Link 02/2014
1	2-pyroneIBA 09/2013
1	butenolideIBA 09/2013
1	LactonesIBA 09/2013
1	Guanidine (Guanidine Nitrate)FDA Link 01/2012
1	PhenylglyoxalIBA 01/2012
1	CatalaseIBA 01/2012
1	TeaIBA 07/2011
1	MutagensIBA 03/2011
1	Histone Deacetylase InhibitorsIBA 01/2011
1	fisetinIBA 02/2010
1	QuercetinIBA 02/2010
1	myricetinIBA 02/2010
1	ApigeninIBA 02/2010
1	SeleniumIBA 11/2008
1	Trace Elements (Biometals)IBA 11/2008
1	Selenious Acid (Selenite)IBA 11/2008
1	NK314IBA 08/2008
1	Indicators and Reagents (Reagents)IBA 06/2008
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 06/2008
1	CurcuminIBA 12/2007
1	PhytochemicalsIBA 12/2007
1	LuteolinIBA 05/2007
1	GenisteinIBA 05/2007
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 07/2006
1	1- (4- dimethylaminomethylphenyl)- 8,9- dihydro- 7H- 2,7,9a- benzo(cd)azulen- 6- oneIBA 12/2005
1	CamptothecinIBA 12/2005
1	Cardiac GlycosidesIBA 11/2005
1	GlycosidesIBA 11/2005
1	Digoxin (Digitek)FDA LinkGeneric 11/2005
1	2-(morpholin-4-yl)benzo(h)chromen-4-oneIBA 06/2004
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 10/2003
1	Cisplatin (Platino)FDA LinkGeneric 07/2003
1	AnthraquinonesIBA 07/2003
1	AlchemixIBA 07/2003
1	Sepharose (Agarose)IBA 05/2002

Therapy/Procedure

9	Therapeutics 03/2024 - 06/2004
5	Drug Therapy (Chemotherapy) 01/2017 - 11/2005